THESEUS PHARMACEUTICALS
Theseus Pharmaceuticals is a technology-based company.
THESEUS PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Health Care Information Technology Pharmaceutical Travel
Founded:
2017-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.theseusrx.com
Total Employee:
11+
Status:
Active
Contact:
2127396493
Total Funding:
120 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
BuildPay
BuildPay is a technology is a web-based company.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Femtosense
Femtosense is a technology company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Magpie Pharmaceuticals
Magpie Pharmaceuticals is a biotechnology company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Practice
Practice is an information technology company.
Shop the Creative
Shop the Creative is a Technology based company.
Structural Health Systems
Structural Health Systems is a Technology based company.
Turing Holdings
Turing Holdings is a Technology Company.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Rock Springs Capital
Rock Springs Capital investment in Series B - Theseus Pharmaceuticals
OrbiMed
OrbiMed investment in Series B - Theseus Pharmaceuticals
Adage Capital Management
Adage Capital Management investment in Series B - Theseus Pharmaceuticals
Longitude Capital
Longitude Capital investment in Series B - Theseus Pharmaceuticals
Nextech Invest
Nextech Invest investment in Series B - Theseus Pharmaceuticals
Omega Funds
Omega Funds investment in Series B - Theseus Pharmaceuticals
Farallon Capital Management
Farallon Capital Management investment in Series B - Theseus Pharmaceuticals
Boxer Capital
Boxer Capital investment in Series B - Theseus Pharmaceuticals
Foresite Capital
Foresite Capital investment in Series B - Theseus Pharmaceuticals
Pontifax
Pontifax investment in Series B - Theseus Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2021-12-16 | Theseus Pharmaceuticals Appoints Alicja Januszewicz as Senior Vice President, People and Culture |
Official Site Inspections
http://www.theseusrx.com Semrush global rank: 5.06 M Semrush visits lastest month: 1.63 K
Unable to get host informations!!!
More informations about "Theseus Pharmaceuticals"
Theseus Pharmaceuticals - Crunchbase Company …
Theseus Pharmaceuticals is a technology-based company. View contacts for Theseus Pharmaceuticals to access new leads and connect with decision-makers.See details»
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by ...
Dec 22, 2023 Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus" or the "Company"), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients …See details»
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by ...
CAMBRIDGE, Mass., Dec. 22, 2023 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus" or the "Company"), a clinical-stage biopharmaceutical company focused on …See details»
Theseus - Overview, News & Similar companies | ZoomInfo.com
THRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Theseus Pharmaceuticals, Inc. Is Fair to Shareholders NEW YORK--(BUSINESS WIRE)--Halper Sadeh …See details»
Company Description - Stock Analysis
Oct 7, 2021 Ticker Symbol: THRX: Exchange: NASDAQ: Fiscal Year: January - December: Reporting Currency: USD: IPO Price: $16.00: CIK Code: 0001745020: CUSIP Number: …See details»
Theseus Pharmaceuticals Inc - Company Profile and News
Company profile page for Theseus Pharmaceuticals Inc including stock price, company news, executives, board members, and contact informationSee details»
Theseus Pharmaceuticals, Inc. (THRX) - Stock Analysis
Feb 13, 2024 Website https://theseusrx.com. Full Company Profile. Financial Performance. Financial Statements. Analyst Forecast. According to 5 analysts, the average rating for THRX …See details»
Theseus Pharmaceuticals to Be Acquired by Concentra …
Dec 22, 2023 Theseus Pharmaceuticals, Inc. (NASDAQ: THRX), a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development, and commercialization of transformative …See details»
Theseus Pharmaceuticals Confirms Receipt of Unsolicited …
On November 22, 2023, the board of directors (the Board) of Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company) received an unsolicited joint letter from funds …See details»
SEC.gov | HOME
For more information, visit www.theseusrx.com. Cautionary Statement Regarding Forward Looking Statements . This release contains “forward-looking statements” within the meaning of …See details»
Theseus Pharmaceuticals Announces Process to Explore Strategic ...
Nov 13, 2023 --Theseus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development, and …See details»
Theseus Pharmaceuticals Announces Business and Pipeline
Aug 11, 2022 Before joining Theseus, he served as Vice President, Head of Quality Assurance at Epizyme, Inc., where he initiated the GxP Quality Assurance organization. Second Quarter …See details»
Theseus Pharmaceuticals Enters into Agreement to Be Acquired by ...
Dec 22, 2023 For more information, visit www.theseusrx.com. Cautionary Statement Regarding Forward Looking Statements. This release contains “forward-looking statements” within the …See details»
Theseus Pharmaceuticals Announces Business and Program …
CAMBRIDGE, Mass., Nov. 15, 2021 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX), a biopharmaceutical company focused on improving the lives of cancer patients …See details»
Theseus Pharmaceuticals Announces Process to Explore Strategic …
CAMBRIDGE, Mass., Nov. 13, 2023 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on …See details»
Theseus Pharmaceuticals Nominates THE-349, a Fourth ... - BioSpace
Oct 3, 2022 Theseus is also developing THE-349, a fourth-generation, selective epidermal growth factor receptor (EGFR) inhibitor for C797X-mediated resistance to first- or later-line …See details»
Theseus Pharmaceuticals to Present Preclinical Data Characterizing …
Mar 8, 2022 For more information, visit www.theseusrx.com. Cautionary Statement Regarding Forward Looking Statements Certain statements included in this press release are not …See details»
Theseus Pharmaceuticals Announces Business and Pipeline …
Nov 3, 2022 Theseus is a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of …See details»
Theseus Pharmaceuticals to Participate at Upcoming September …
CAMBRIDGE, Mass., Sept. 6, 2022 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) (Theseus or the Company), a clinical-stage biopharmaceutical company focused on …See details»
Theseus Pharmaceuticals Announces FDA Clearance of …
Nov 1, 2021 For more information, visit www.theseusrx.com. Cautionary Statement Regarding Forward Looking Statements Certain statements included in this press release are not …See details»